These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis. Sumrall A; Dreiling B J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the myocardial performance index for early detection of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis. Pattoneri P; Pelà G; Montanari E; Pesci I; Moruzzi P; Borghetti A Eur J Echocardiogr; 2007 Mar; 8(2):144-50. PubMed ID: 16603413 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy and multiple sclerosis: The devil is in the details. Bourdette D; Whitham R Neurology; 2010 May; 74(18):1410-1. PubMed ID: 20439842 [No Abstract] [Full Text] [Related]
16. [Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis]. Feuillet L; Guedj E; Eusebio A; Malikova I; Pelletier J; Mundler O; Ali Chérif A; Rev Neurol (Paris); 2003 Dec; 159(12):1169-72. PubMed ID: 14978418 [TBL] [Abstract][Full Text] [Related]
17. [Mitoxantrone, a new reality]. Ruiz-Peña JL; Izquierdo G Rev Neurol; 2003 Apr 1-15; 36(7):698-9. PubMed ID: 12666055 [No Abstract] [Full Text] [Related]
18. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
19. The first case of mitoxantrone exposure in early pregnancy. De Santis M; Straface G; Cavaliere AF; Rosati P; Batocchi AP; Caruso A Neurotoxicology; 2007 May; 28(3):696-7. PubMed ID: 17227680 [TBL] [Abstract][Full Text] [Related]
20. Rationale for the use of mitoxantrone in multiple sclerosis. Edan G; Morrissey S; Le Page E J Neurol Sci; 2004 Aug; 223(1):35-9. PubMed ID: 15261558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]